You searched for "regeneration"

2248 results found

Undetected retinoblastoma management following vitrectomy

This retrospective study from a single-centre referral university hospital in Germany analysed data collected between 1991-2019 to comment on management and complications of undetected retinoblastoma eyes following vitrectomy. The 10 patients included had a mean age of 36.1 months (range...

Alternative diagnosis in cases of poor response to amblyopia therapy

The aim of this study was to assess the prevalence of coexistent ocular pathology and identify / describe the factors that contribute to undiagnosed alternate diagnosis and / or co-existent pathology at initial presentation in patients referred as potentially amblyopic....

HS-UK to be authorised distributor for the Vision Engineering 3D Deep Reality Viewer

HS-UK is delighted to announce that it is now the authorised distributor for the Deep Reality Viewer (DRV) in the UK.

Scope Ophthalmology announce case awards winners

Scope Eyecare are delighted to announce the winners of the Scope Ophthalmology case awards UK and Ireland for 2023.

Surgical options for the treatment of hyperopia

The modern refractive surgeon has a variety of options available to treat patients with hyperopia who wish to be independent of spectacles and contact lenses. Unlike in low myopia where presbyopic patients may have the ability to see well for...

An Introduction to: RCOphth's Microsurgery Course

For foundation doctors and medical students with a keen interest on becoming ophthalmologists, the RCOphth Microsurgery Introduction Course stands as a gateway to introducing doctors to the intricacies of microsurgery.

Adjuvant oral voriconazole or oral ketoconazole for fungal keratitis

This randomised double-blinded trial examined clinical outcomes of 50 patients with severe fungal keratitis treated with either adjuvant oral voriconazole or oral ketoconazole. Inclusion criteria were culture or smear proven fungal ulcers >5mm in maximum diameter, involving >4mm of the...

Intracameral bevacizumab as an adjunct to trabeculectomy

This is a 12-month, prospective, randomised, double-masked, placebo-controlled trial of patients who were not controlled medically with open angle glaucoma and scheduled for a primary trabeculectomy. Patients were recruited and randomised during the period between April 2009 and November 2010....

Hypothyroidsim and acute central serous chorioretinopathy – is there a link?

This cross-sectional study included 71 consecutive acute central serous chorioretinopathy (CSC) patients and 70 age-matched healthy control subjects. Systemic findings, including serum levels of thyroid hormones, thyroid stimulating hormone (TSH), mean arterial pressure (MAP), pulse rate, serum lipid levels and...

Atropine treatment for myopia in western countries – rationale

This preliminary study sets out the rationale, methodology and participant baseline characteristics for the Western Australia Atropine for the Treatment of Myopia (WA-ATOM). It is a double masked randomised placebo-controlled trial. This study is designed to be combined with the...

CHEC achieves Investors in People status

CHEC, one of the largest providers of community-based ophthalmology services in the UK, has achieved Investors in People status, with its company values and culture pinpointed as being fundamental to the company’s success.

RNIB CEO to step down in December 2025

Matt Stringer, Chief Executive of the Royal National Institute of Blind People (RNIB) has announced that he will be stepping down from his role. Matt has led RNIB through some challenging times such as the statutory inquiry, the Covid-19 pandemic...